Sign in
4

Changes in Ownership

Spero Therapeutics, Inc. Filed Acc 0000950170-24-066659

Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Deshpande Milind Director 2024-05-29 Grant or award +20,000 71,454 D
Loading xslF345X05/ownership.xml…